COMPX INTERNATIONAL INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data COMPX INTERNATIONAL INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	109	112	118	124	115	141	167	161	146	158
Cost of revenue	73.8	77.2	79.9	85.3	81.7	98.1	118	112	105	110
Gross profit	35.2	34.8	38.3	39	32.8	42.7	48.8	49.2	41.4	48.2
Selling, general and administrative	19.6	19.6	20.5	21.3	21	22.2	23.4	23.8	24.3	25.6
Operating income	15.6	15.2	17.8	17.7	11.8	20.5	25.4	25.4	17	22.6
Interest income	0.39	1.93	2.66
Pre-tax income	16	17.2	20.5	20.9	13.5	21.7	27.3	29.6	21.7	25.8
Income tax	5.51	3.96	5.15	4.94	3.17	5.16	6.44	7.01	5.15	6.36
Net income	10.5	13.2	15.3	16	10.3	16.6	20.9	22.6	16.6	19.5
EBITDA	19.3	18.9	21.3	21.4	15.6	24.4	29.4	29.4	20.7	26.3
EPS, basic	0.84	1.06	1.23	1.29	0.83	1.34	1.69	1.84	1.35	1.58
EPS, diluted	0.84	1.06	1.23	1.29	0.83	1.34	1.69	1.84	1.35	1.58
Shares, basic (weighted)	12.4	12.4	12.4	12.4	12.4	12.4	12.3	12.3	12.3	12.3
Shares, diluted (weighted)	12.4	12.4	12.4	12.4	12.4	12.4	12.3	12.3	12.3	12.3
Dividend per share	0.05	0.05	0.05	0.07	0.10	0.20	0.25	0.25	0.30	0.30

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	33.2	29.7	45.4	63.3	70.6	76.6	26.7	41.4	60.8	54.1
Short-term investments							33.1	35.4
Receivables	10.3	10.4	12.1	11.9	10.7	15.5	17.8	17.1	14.1	13.8
Inventory	15	15.4	17.1	18.3	18.3	25.6	31.3	30.7	28.4	30.4
Other current assets	0.7	0.88	1.63	1.62	1.54	2.46	2.14	2.11	2.04	1.83
Total current assets	59.2	56.4	76.3	95.1	101	120	111	127	105	100
Property, plant and equipment	33.1	32.1	31.8	31	29	29.2	28.7	25.9	24	23.7
Goodwill	23.7	23.7	23.7	23.7	23.7	23.7	23.7	23.7	23.7	23.7
Other non-current assets	0.59	0.59	0.59	0.59	0.61	0.6	0.59	0.77	0.68	0.65
Total assets	144	151	166	179	184	192	177	188	163	156
Accounts payable	2.61	10.8	12.5	12.1	12.2	14.7	15.6	15.7	15	15.3
Accrued liabilities	7.64	7.41	8.07	8.33	8.43	9.8	10.5	10.7	9.79	11.2
Deferred revenue							0.24	0.56	0.1	0.05
Total current liabilities	13.3	11.3	13.7	13.1	13.2	16.4	16.7	17.2	15.8	17
Other non-current liabilities							0.07	0.04	0.06	0.11
Total liabilities	18.2	14.4	16.9	16.3	16.4	19.4	19	18.8	16.9	17.6
Paid-in capital	55.5	55.6	55.8	55.9	56	54.8	53.2	53.3	53.4	53.5
Retained earnings	70.1	80.8	93.7	106	112	118	105	115	92.6	85
Shareholders' equity	126	137	150	162	168	173	158	169	146	139
Total equity	126	137	150	162	168	173	158	169	146	139
Total liabilities and equity	144	151	166	179	184	192	177	188	163	156
Shares outstanding			12.4	12.4	12.5	12.4	12.3	12.3	12.3	12.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	10.5	13.2	15.3	16	10.3	16.6	20.9	22.6	16.6	19.5
Depreciation and amortization	3.7	3.67	3.45	3.68	3.83	3.84	3.98	3.97	3.69	3.65
Deferred income tax	-0.11	-1.78	0.09	0.09	-0.05	-0.32	-0.69	-0.72	-0.44	-0.69
Change in receivables	-1.6	-0.12	-1.71	0.25	1.12	-4.81	-2.31	0.76	2.91	0.33
Change in inventory	-0.04	-0.47	-1.85	-1.44	-0.19	-7.48	-5.83	0.33	2.13	-2.33
Change in payables	0.15	-0.96	1.62	-0.4	0.1	2.55	0.94	0.1	-1.21	0.77
Cash from operations	13.9	12.6	17.2	18.5	15.5	10.5	16.9	25.8	22.9	22.9
Capital expenditures	-3.18	-2.8	-3.12	-3.17	-1.74	-4.09	-3.7	-1.13	-1.43	-3.75
Purchases of investments							-33	-36.3
Cash from investing	-30.6	-13.6	1.08	2.86	-3.14	6.71	-31.1	1.15	35.9	-2.45
Share buybacks						-1.31	-1.74
Dividends paid	-2.48	-2.49	-2.49	-3.48	-4.98	-9.93	-33.9	-12.3	-39.4	-27.1
Cash from financing	-2.48	-2.49		-3.48	-4.98	-11.2	-35.6	-12.3	-39.4
Net change in cash	-19.2	-3.5	15.8	17.8	7.38	5.94	-49.8	14.6	19.4	-6.69
Free cash flow	10.7	9.79	14	15.3	13.8	6.38	13.2	24.7	21.5	19.1
Income taxes paid	4.65	6.71	4.37	5.03	3.26	4.7	7.82	7.31	6.25	6.12

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $37.80 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.1%	Gross profit / revenue.
Operating margin	16.3%	Operating income / revenue.
EBITDA margin	18.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	18.1%	Pre-tax income / revenue.
Net margin	13.6%	Net income / revenue.
FCF margin	13.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	15.0%	Cash from operations / revenue.
Effective tax rate	24.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	15.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	13.6%	Net income / average total assets.
Return on invested capital (ROIC)	21.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	15.8%	Selling, general and administrative expense / revenue.
Capex / revenue	1.9%	Capital expenditures / revenue.
D&A / revenue	2.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	16.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	8.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	32.8%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-3.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	13.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	26.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-3.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	10.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	17.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-2.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	13.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	17.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-2.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	13.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-0.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	10.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	8.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-11.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	13.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	6.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.3%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	24.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-5.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-4.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-3.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-4.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-3.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	6.69x	Current assets / current liabilities.
Quick ratio	4.55x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	3.31x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	10.4%	Total liabilities / total assets.
Working capital	$90.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	14.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$120.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.00x	Revenue / average total assets.
Fixed asset turnover	6.89x	Revenue / average property, plant and equipment.
Inventory turnover	3.46x	Cost of revenue / average inventory.
Days inventory	105 days	365 x average inventory / cost of revenue.
Receivables turnover	8.27x	Revenue / average receivables.
Days sales outstanding	44 days	365 x average receivables / revenue.
Days payables	47 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	103 days	Days inventory + days sales outstanding - days payables.
FCF conversion	96.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	12.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1,785.00	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$13,126.00	Revenue / diluted weighted shares.
FCF per share	$1,721.00	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1,973.00	Cash from operations / diluted weighted shares.
Book value per share	$11,734.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$9,808.00	Tangible book value / shares outstanding.
Cash per share	$4,252.00	(Cash + short-term investments) / shares outstanding.
Payout ratio	123.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	127.8%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$466.3M	Share price x shares outstanding.
Enterprise value	$413.9M	Market cap + total debt - cash - short-term investments.
P/E	21.2x	Market cap / net income. Only when net income is positive.
P/S	2.88x	Market cap / revenue.
P/B	3.22x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.86x	Market cap / tangible book value, when positive.
P/FCF	22.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	19.2x	Market cap / cash from operations, when positive.
EV/Sales	2.56x	Enterprise value / revenue.
EV/EBIT	15.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	19.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.6%	Free cash flow / market cap.
Earnings yield	4.7%	Net income / market cap (the inverse of P/E).
Dividend yield	5.8%	Dividends paid over the period / market cap.
Shareholder yield	5.8%	(Dividends paid + share buybacks) / market cap.

What was COMPX INTERNATIONAL INC's revenue in fiscal 2025?

COMPX INTERNATIONAL INC reported revenue of $158.3M for fiscal 2025, 8.5% higher than the year before.

Was COMPX INTERNATIONAL INC profitable in fiscal 2025?

Yes. Net income was $19.5M, a net margin of 12.3%.

How much free cash flow did COMPX INTERNATIONAL INC generate in fiscal 2025?

Cash from operations of $22.9M minus capital expenditures of $3.7M left free cash flow of $19.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to COMPX INTERNATIONAL INC